Proportion of the GSTM 10/0 genotype in some slavic populations and its correlation with cystic fibrosis and some multifactorial diseases VS Baranov, T Ivaschenko, B Bakay, M Aseev, R Belotserkovskaya, ... Human genetics 97, 516-520, 1996 | 193 | 1996 |
Peculiarities of GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. MP Baranova H, Perriot J, Albuisson E, Ivaschenko T, Baranov VS, Hemery B ... Hum Genet. 99 (6), 822-6, 1997 | 158 | 1997 |
Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial P Mercié, J Arsandaux, C Katlama, S Ferret, A Beuscart, C Spadone, ... The lancet HIV 5 (3), e126-e135, 2018 | 61 | 2018 |
Tabacologie et sevrage tabagique J Perriot, PM Llorca John Libbey Eurotext, 2003 | 51 | 2003 |
Environmental causes of asthma DW Cockcroft Seminars in respiratory and critical care medicine 39 (01), 012-018, 2018 | 50 | 2018 |
La conduite de l’aide au sevrage tabagique J Perriot Revue des maladies respiratoires 23 (1), 3S85-3S105, 2006 | 48 | 2006 |
Hypersexuality and pathological gambling in Parkinson's disease: A cross‐sectional case–control study I de Chazeron, PM Llorca, I Chéreau‐Boudet, O Blanc, J Perriot, ... Movement disorders 26 (11), 2127-2130, 2011 | 41 | 2011 |
Influence de l’anxiété et de la dépression sur les exacerbations au cours de la BPCO M Underner, A Cuvelier, G Peiffer, J Perriot, N Jaafari Revue des maladies respiratoires 35 (6), 604-625, 2018 | 36 | 2018 |
Les effets indésirables des antituberculeux; prise en charge J Perriot, É Chambonnet, A Eschalier Revue des maladies respiratoires 28 (4), 542-555, 2011 | 36 | 2011 |
Cannabis smoking and lung cancer M Underner, T Urban, J Perriot, I De Chazeron, JC Meurice Revue des maladies respiratoires 31 (6), 488-498, 2014 | 35 | 2014 |
Success rates in smoking cessation: Psychological preparation plays a critical role and interacts with other factors such as psychoactive substances B Joly, J Perriot, P D’athis, E Chazard, G Brousse, C Quantin PLoS One 12 (10), e0184800, 2017 | 34 | 2017 |
Smoking cessation in smokers with chronic obstructive pulmonary disease M Underner, J Perriot, G Peiffer Revue des maladies respiratoires 31 (10), 937-960, 2014 | 31 | 2014 |
Executive functions in tobacco dependence: importance of inhibitory capacities V Flaudias, MC Picot, J Lopez-Castroman, PM Llorca, A Schmitt, J Perriot, ... PLoS one 11 (3), e0150940, 2016 | 30 | 2016 |
Le sevrage tabagique des «fumeurs difficiles» J Perriot, M Underner, G Peiffer, J Le Houezec, L Samalin, A Schmitt, ... Revue des maladies respiratoires 29 (4), 448-461, 2012 | 30 | 2012 |
Smoking and tuberculosis M Underner, J Perriot Presse Medicale (Paris, France: 1983) 41 (12 Pt 1), 1171-1180, 2012 | 29 | 2012 |
Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial—a randomized study in smokers with medical comorbidities I Berlin, N Jacob, M Coudert, J Perriot, L Schultz, N Rodon Addiction 106 (4), 833-843, 2011 | 28 | 2011 |
Tuberculosis and tobacco smoking J Perriot, M Underner, G Peiffer Journal of Tuberculosis 1 (1004), 1-4, 2018 | 27 | 2018 |
Les tests d’évaluation de la dépendance tabagique M Underner, J Le Houezec, J Perriot, G Peiffer Revue des maladies respiratoires 29 (4), 462-474, 2012 | 26 | 2012 |
Practical guidelines on e-cigarettes for practitioners and others health professionals. A French 2016 expert's statement B Dautzenberg, M Adler, D Garelik, JF Loubrieu, G Mathern, G Peiffer, ... Revue des Maladies Respiratoires, 2017 | 25 | 2017 |
Influence du tabagisme sur le risque de développement de l’asthme M Underner, J Perriot, G Peiffer, JC Meurice Revue des Maladies Respiratoires 32 (2), 110-137, 2015 | 23 | 2015 |